The purpose of this study is to test the efficacy of brief behavioral therapy versus control
condition that accounts for time and attention (nutrition education) in the treatment of
insomnia in humans.
To assess the impact of different biomarkers on sleep disruption and other patient reported
- Be female and have a diagnosis of Breast Cancer (Stage I-IIIA).
- Be scheduled for planned cancer treatment (e.g. chemotherapy or biologics such as
- Have at least 6 weeks of cancer treatment (e.g. chemotherapy or biologics such as
- Be at least 21 years of age.
- Be able to understand written and spoken English.
- Report sleep disturbance of 8 or greater on the ISI, and report insomnia that began
or got worse with diagnosis of cancer or treatment with chemotherapy (to exclude
pre-existing, chronic insomnia).
- Have a Karnofsky score >= 70 to ensure that patients are able to participate in
intervention and assessments.
- Have an unstable self-reported medical or psychiatric illness (Axis I - current or
within the last 5 years).
- Be currently pregnant or nursing (patients are monitored for pregnancy during
chemotherapy and pregnant women in the first trimester are not administered
chemotherapy. Therefore, pregnancy status of women will be known prior to the
entrance to the study).
- Have a history of substance abuse or meet criteria for current alcohol abuse or
- Have a self-reported history of sleep apnea or restless leg syndrome (RLS)
- Self-report or have a medical record of an unstable comorbid medical or psychiatric
condition that would make it unsafe or impossible to adhere to the study protocol
- Are unable or unwilling to discontinue anxiolytics within 4 hours of education
- Have irregular heartbeats or arrhythmia (self-reported or in the medical record)